Emily Farber - Concepedia

Author

Emily Farber

Also Known As

Anna Lisa Fear, E. A. Farber, E. Farber, Emily A Farber, Emily A. Farber, Emily Farber, Emily A. Farber, Evgeny Farber, Farber, Emily, Ilana Kelland

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

University of Virginia University of California, Los Angeles University of Washington Office of Public Health Genomics University of California, San Francisco

About

Emily Farber is an author at University of Virginia specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	3.1K
2	Health Sciences	3	3	420
3	Natural Sciences	3	3	668
4	Public Health	2	2	80
5	Social Sciences	1	1	86

Emily Farber

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease Sandro Dá Mesquita, Antoine Louveau, Andrea Vaccari, Nature Alzheimer's DiseaseFunctional AspectsLymphatic SystemDegenerative PathologyNeurology	2018	1.3K
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers Suna Önengüt-Gümüşcü, Wei‐Min Chen, Oliver S. Burren, Nature Genetics	2015	729
Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons Anne P. Beigneux, Brandon S.J. Davies, Peter Gin, Cell Metabolism Proteinlipid InteractionBiochemistryLipolytic ProcessingCritical RoleNatural Sciences	2007	457
Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy Sandro Dá Mesquita, Zachary Papadopoulos, Taitea Dykstra, Nature Meningeal LymphaticsMedicineImmunologyLymphatic SystemBrain-immune Interaction	2021	375
Microbiota alteration is associated with the development of stress-induced despair behavior Ioana Marin, Jennifer E. Goertz, Tiantian Ren, Scientific Reports	2017	365
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes Catherine C. Robertson, Jamie Inshaw, Suna Önengüt-Gümüşcü, Nature Genetics Causal VariantsType 1Genome-wide Association StudyGenetic DeterminantGenotype-phenotype Association	2021	282
Glucagon Regulates Hepatic Kisspeptin to Impair Insulin Secretion Woo‐Jin Song, Prosenjit Mondal, Andrew Wolfe, Cell Metabolism Metabolic SyndromeSignal TransductionMolecular PhysiologyBiochemistryInsulin Management	2014	205
Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency Catherine Coffinier, Sandy Y. Chang, Chika Nobumori, Proceedings of the National Academy of Sciences Brain DevelopmentNeurological DisorderNuclear LaminaCellular NeurobiologyNeurobiology Of Disease	2010	159
Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk Adam W. Turner, Shengen Shawn Hu, José Verdezoto Mosquera, Nature Genetics ChromatinCardiovascular DiseaseChromatin RemodelingAtherosclerosisGenetics	2022	143
HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells Catherine Coffinier, Sarah E. Hudon, Emily Farber, Proceedings of the National Academy of Sciences Hiv Protease InhibitorsImmunologyMolecular BiologyCytoskeletonZinc Metalloproteinase Zmpste24	2007	132

Page 1